clopidogrel has been researched along with Disease Exacerbation in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 26 (59.09) | 24.3611 |
| 2020's | 4 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kwaan, H; Lindholm, PF; Luo, Y; Metcalf-Doetsch, W; Naidech, AM; Shin, HJ; Tang, M | 1 |
| Bocchino, PP; D'Ascenzo, F; De Ferrari, GM; De Filippo, O; Imazio, M; Piroli, F; Scacciatella, P | 1 |
| Alvikas, J; Doberstein, C; Guillotte, AR; Joseph, B; Myers, SP; Neal, MD; Okonkwo, DO; Pelaez, C; Rosengart, MR; Wessel, CB | 1 |
| Baumgartner, I; Berger, JS; Blomster, JI; Fowkes, FG; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, K; Mulder, H; Narcisse, DI; Norgren, L; Patel, MR; Rockhold, F; Rymer, JA | 1 |
| Colgan, MP; Coughlan, T; Doherty, CP; Egan, B; Feeley, TM; Hamilton, G; Harbison, JA; Kinsella, JA; Madhavan, P; McCabe, DJH; Moore, DJ; Moran, N; Murphy, RP; O'Neill, D; O'Neill, SM; Oliver Tobin, W; Ronan Collins, D; Saqqur, M; Tierney, S | 1 |
| Lu, M | 1 |
| Ikeda-Sakai, Y; Nakase, T; Sasaki, M | 1 |
| Tan, Z; Wang, W; Xiao, W; Xu, A; Yang, W; Zeng, J; Zhao, Y | 1 |
| Chai, Z; Han, Z; Huang, R; Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
| Badalato, GM; Hruby, GW; Lipsky, MJ; McKiernan, JM; Motamedinia, P | 1 |
| Aziz, H; Friese, RS; Joseph, B; Kulvatunyou, N; O'Keeffe, T; Pandit, V; Rhee, P; Sadoun, M; Tang, A; Wynne, JL | 1 |
| Eckl, S; Ensminger, SM; Goldmann, K; Heim, C; Koch, N; Preidl, R; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M | 1 |
| Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P | 1 |
| Chen, F; Cheng, G; Fang, Y; Guo, Y; Li, H; Liu, D; Liu, F; Liu, L; Liu, Z; Margetts, P; Tang, L; Zhao, Z | 1 |
| Akasaka, T; Hanawa, K; Hao, K; Hasebe, Y; Hirano, M; Ito, K; Matsumoto, Y; Miyata, S; Nishimiya, K; Ogata, T; Oyama, K; Shimokawa, H; Shindo, T; Takahashi, J; Tanaka, A; Taruya, A; Tsuburaya, R; Uzuka, H | 1 |
| Ensminger, SM; Gebhardt, J; Heim, C; Jacobi, J; Ramsperger-Gleixner, M; Weyand, M | 1 |
| Ansel, GM; Dake, MD; Jaff, MR; Machan, LS; O'Leary, EE; Ohki, T; Ragheb, AO; Saxon, RR; Smouse, HB; Snyder, SA; Zeller, T | 1 |
| Jing, J; Johnston, SC; Li, H; Li, Z; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, D; Wang, X; Wang, Y; Xian, Y; Yang, X; Zhang, C; Zhao, X | 1 |
| Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FG; Heizer, G; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Millegård, M; Norgren, L; Patel, MR; Reist, C | 1 |
| Aharonian, V; Brar, SK; Brar, SS; Hyett, R; Kim, J; Liu, IL; Mansukhani, P; Ree, M; Shen, AY; Zadegan, R | 1 |
| Choi, SH; Prasad, A; Tsimikas, S | 1 |
| Alberts, MJ | 1 |
| Alberts, MJ; Batjer, HH; Bendok, BR; Bernstein, RA; Bleck, TP; Garg, RK; Naidech, AM | 1 |
| Clemmensen, P; Engstrøm, T; Helqvist, S; Holmvang, L; Jensen, JS; Jørgensen, E; Kelbaek, H; Lønborg, J; Saunamäki, K; Treiman, M; Vejlstrup, N | 1 |
| Jezovnik, MK; Poredos, P | 1 |
| Mayer, TE; Reinhöfer, M; Weise, J; Witte, OW | 1 |
| Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH | 1 |
| Akazawa, Y; Hirata, A; Kashiwase, K; Kashiyama, T; Kodama, K; Masumura, Y; Matsuo, K; Muller, JE; Nemoto, T; Nishio, M; Ueda, Y; Wada, M | 1 |
| Bauersachs, J; Flierl, U; Kobsar, A; Kössler, J; Schäfer, A; Seydelmann, N; Störk, S | 1 |
| Bae, HJ; Cho, YJ; Han, MK; Hong, KS; Jeong, SW; Kang, DW; Kim, DE; Kim, GM; Kim, HY; Kim, JS; Koo, JS; Kwon, SU; Lee, BC; Lee, JH; Lee, KB; Lee, SH; Lee, YS; Mok, VC; Nah, HW; Park, JM; Rha, JH; Suwanwela, NC; Wong, KS; Yu, KH; Yun, SC | 1 |
| Baiocco, P; Korelitz, BI; Panagopoulos, G; Sonpal, N; Vadada, D; Vinod, J | 1 |
| Greenhill, C | 1 |
| Duan, CZ; Gu, DQ; Long, XA; Luo, B; Zhang, X | 1 |
| Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT | 1 |
| Bell, PR; Goodall, AH; Hayes, PD; Jones, CI; London, NJ; Naylor, AR; Payne, DA; Thompson, MM | 1 |
| André-Fouët, X; Boschat, J; Finet, G; Gilard, M; Ginon, I; Rioufol, G | 1 |
| Shamalov, NA; Skvortsova, VI | 1 |
| Andre, P; Conley, PB; Phillips, DR; Sinha, U | 1 |
| Jug, B; Keber, I; Sabovic, M; Sebestjen, M | 1 |
| Cha, JK; Jeon, HW | 1 |
| Harish, CR; Satish, B; Tressa, K | 1 |
| Koellnberger, M; Konrad, I; Lorenz, R; Massberg, S; Orschiedt, L; Sauer, S; Schulz, C; Walter, U | 1 |
| Andreozzi, GM; Arosio, E; Martini, R; Verlato, F; Visonà, A | 1 |
| Fonarow, GC; Horwich, TB | 1 |
4 review(s) available for clopidogrel and Disease Exacerbation
| Article | Year |
|---|---|
A systematic review and meta-analysis of traumatic intracranial hemorrhage in patients taking prehospital antiplatelet therapy: Is there a role for platelet transfusions?
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Disease Progression; Humans; Intracranial Hemorrhage, Traumatic; Platelet Aggregation Inhibitors; Platelet Transfusion; Practice Guidelines as Topic; Precipitating Factors; Treatment Outcome | 2020 |
Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
Topics: Administration, Oral; Aspirin; Cardiovascular Diseases; Clopidogrel; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Treatment Outcome | 2010 |
Therapeutic approaches in arterial thrombosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Disease Progression; Fibrinolytic Agents; Humans; Mice; Models, Biological; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk; Signal Transduction; Thrombosis; Ticlopidine; Time Factors | 2005 |
Prevention of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Disease Progression; Health Behavior; Heart Failure; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Prevalence; Renal Insufficiency; Risk Factors; Smoking; Ticlopidine; Ventricular Dysfunction, Left | 2002 |
13 trial(s) available for clopidogrel and Disease Exacerbation
| Article | Year |
|---|---|
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Topics: Aged; Amputation, Surgical; Cardiovascular Diseases; Clopidogrel; Comorbidity; Disease Progression; Female; Humans; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Risk Factors; Symptom Assessment; Ticagrelor; Treatment Outcome | 2020 |
Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Chi-Square Distribution; China; Clopidogrel; Cytochrome P-450 CYP2C19; Disease Progression; Drug Therapy, Combination; Female; Genotype; Humans; Incidence; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pantoprazole; Pharmacogenomic Variants; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial.
Topics: Aged; China; Clopidogrel; Disease Progression; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2017 |
Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; China; Clopidogrel; Creatinine; Disease Progression; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Platelet Aggregation Inhibitors; Proteinuria; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Valine; Valsartan | 2015 |
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Drug-Eluting Stents; Equipment Failure; Female; Femoral Artery; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Paclitaxel; Popliteal Artery; Recurrence; Stents; Ticlopidine; Vascular Patency | 2016 |
Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
Topics: Aged; Aspirin; Chi-Square Distribution; China; Clopidogrel; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Secondary Prevention; Severity of Illness Index; Stroke; Ticlopidine; Time Factors; Time-to-Treatment; Treatment Outcome | 2016 |
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Topics: Adenosine; Aged; Ankle Brachial Index; Clopidogrel; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiotonic Agents; Chemotherapy, Adjuvant; Clopidogrel; Disease Progression; Electrocardiography; Female; Heart Function Tests; Heparin; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Analysis; Ticlopidine | 2010 |
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Aspirin; Carotid Arteries; Carotid Stenosis; Chi-Square Distribution; Cilostazol; Clopidogrel; Coronary Angiography; Disease Progression; Drug Therapy, Combination; Hemorrhage; Humans; Inflammation Mediators; Middle Aged; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Prospective Studies; Republic of Korea; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2011 |
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.
Topics: Aged; Aged, 80 and over; Cilostazol; Clopidogrel; Constriction, Pathologic; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Premedication; Risk; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Wound Healing | 2004 |
[The results of the MATCH study evidence for advantages of Clopidogrel monotherapy as secondary prophylaxis in cerebrovascular pathology].
Topics: Aged; Brain Ischemia; Clopidogrel; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Safety; Ticlopidine; Treatment Outcome | 2004 |
Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiac Output, Low; Clopidogrel; Cross-Over Studies; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
27 other study(ies) available for clopidogrel and Disease Exacerbation
| Article | Year |
|---|---|
Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage.
Topics: Aspirin; Biomarkers; Cerebral Hemorrhage; Clopidogrel; Disease Progression; Hematoma; Hemostasis; Humans; Platelet Aggregation Inhibitors | 2022 |
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.
Topics: Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Treatment Outcome; Warfarin | 2020 |
Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Topics: Aged; Aspirin; Brain; Carotid Stenosis; Case-Control Studies; Clopidogrel; Disease Progression; Female; Humans; Intracranial Embolism; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prevalence; Proof of Concept Study; Ticlopidine; Ultrasonography, Doppler, Transcranial | 2017 |
Effects With and Without Clopidogrel Loading Treatment for Acute Ischemic Cerebrovascular Disease Patients: A Retrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Brain; Brain Ischemia; Clinical Decision-Making; Clopidogrel; Disease Progression; Female; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nerve Degeneration; Neuroprotective Agents; Odds Ratio; Patient Selection; Platelet Aggregation Inhibitors; Propensity Score; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; China; Clinical Decision-Making; Clopidogrel; Cytochrome P-450 CYP2C19; Disease Progression; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Precision Medicine; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2018 |
The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunomodulation; Induction Chemotherapy; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2013 |
Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Cohort Studies; Disease Progression; Female; Head Injuries, Closed; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2014 |
Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts.
Topics: Allografts; Animals; Aorta; Arteriosclerosis; Clopidogrel; Disease Progression; Everolimus; Immunity, Humoral; Isoantibodies; Mice; Mice, Inbred C57BL; Sirolimus; Ticlopidine | 2015 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2014 |
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - .
Topics: Adventitia; Aged; Aged, 80 and over; Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Everolimus; Female; Humans; Interferometry; Male; Middle Aged; Neointima; Neovascularization, Physiologic; Platelet Aggregation Inhibitors; Postoperative Period; Prosthesis Implantation; Sirolimus; Stents; Swine; Swine, Miniature; Ticlopidine; Tomography, Optical Coherence; Vasa Vasorum; Vasculitis | 2015 |
Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Chemokine CCL2; Clopidogrel; Disease Models, Animal; Disease Progression; E-Selectin; Gene Expression Regulation; Genetic Predisposition to Disease; Lipids; Lymphokines; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phenotype; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; RNA, Messenger; Ticlopidine; Time Factors; Vascular Remodeling | 2016 |
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Topics: Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Analysis; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents.
Topics: Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
CHARISMA revisited: is the glass half full or just empty?
Topics: Aspirin; Clopidogrel; Coronary Disease; Disease Progression; Humans; Platelet Aggregation Inhibitors; Primary Prevention; Randomized Controlled Trials as Topic; Registries; Stroke; Ticlopidine | 2008 |
Reduced platelet activity is associated with more intraventricular hemorrhage.
Topics: Adult; Aged; Aspirin; Blood Platelet Disorders; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Comorbidity; Disease Progression; Female; Humans; Lateral Ventricles; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2009 |
Early stent thrombosis with progressive brainstem infarction in a clopidogrel non-responder.
Topics: Aged; Brain Infarction; Brain Ischemia; Clopidogrel; Disease Progression; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2010 |
Frequency and location of yellow and disrupted coronary plaques in patients as detected by angioscopy.
Topics: Acute Coronary Syndrome; Aged; Angioscopy; Aspirin; Clopidogrel; Coronary Artery Disease; Disease Progression; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Ticlopidine | 2011 |
Early determination of clopidogrel responsiveness by platelet reactivity indexidentifies patients at risk for cardiovascular events after myocardial infarction.
Topics: Aged; Clopidogrel; Disease Progression; Drug Resistance; Early Diagnosis; Female; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Function Tests; Predictive Value of Tests; Prognosis; Receptors, Purinergic P2Y12; Reference Values; Ticlopidine; Treatment Outcome | 2011 |
The effect of antiplatelet therapy in patients with inflammatory bowel disease.
Topics: Aspirin; Clopidogrel; Disease Progression; Female; Humans; Inflammatory Bowel Diseases; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine | 2012 |
Hepatocellular carcinoma: could antiplatelet drugs be used to prevent HBV-associated hepatocellular carcinoma?
Topics: Animals; Carcinoma, Hepatocellular; Chemoprevention; Clopidogrel; Disease Models, Animal; Disease Progression; Hepatitis B, Chronic; Humans; Liver Neoplasms; Platelet Aggregation Inhibitors; Ticlopidine | 2012 |
The effect of Neuroform stent-assisted coil embolization of wide-necked intracranial aneurysms and clinical factors on progressive aneurysm occlusion on angiographic follow-up.
Topics: Adult; Aspirin; Cerebral Angiography; Clopidogrel; Disease Progression; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Male; Middle Aged; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome | 2013 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Databases, Factual; Disease Progression; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome | 2013 |
Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound.
Topics: Aged; Aspirin; Biomarkers; Clopidogrel; Coronary Artery Disease; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Rupture, Spontaneous; Ticlopidine; Troponin I; Ultrasonography, Interventional | 2004 |
Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Disease Progression; Female; Humans; Infarction, Middle Cerebral Artery; Logistic Models; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2008 |
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug Hypersensitivity; Drug Therapy, Combination; Exanthema; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tubulin Modulators; Urticaria | 2007 |
Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Topics: Animals; Aorta; Apolipoproteins E; Aspirin; Atherosclerosis; Blood Platelets; Carotid Arteries; Cholesterol, Dietary; Clopidogrel; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Microscopy, Video; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Rupture; Thrombosis; Ticlopidine; Time Factors | 2008 |
Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Disease Progression; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Ultrasonography, Doppler, Color | 2008 |